HCA Healthcare (HCA) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $92.48B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Care Facilities |
| Country | US | CEO | Samuel N. Hazen |
| IPO Date | 2011-03-10 | CAGR | 17.44% |
| Employees | 320,000 | Website | www.hcahealthcare.com |
| Div. Yield | 0.14% | Payout Ratio | 10% |
| Buy Back Yield | 1.94% | Total Yield | 2.08% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $142.34B | P/E | 14.75 | Forward P/E | 13.35 | PEG | 1.24 |
| P/S | 5.76 | P/B | -68.62 | P/CF | 40.62 | P/FCF | 74.95 |
| Sales | $78.01B | Sales 1Y | 7.31% | Sales 3Y | 25.99% | Sales 5Y | 39.27% |
| EPS | $28.96 | EPS 1Y | 25.5% | EPS 3Y | 46.93% | EPS 5Y | 104.87% |
| Sales QoQ | 5.87% | EPS QoQ | 6.57% | Sales QoQ Avg | 2.16% | EPS QoQ Avg | 3.32% |
| Gross Margin | 28.36% | Operating Margin | 15.48% | Profit Margin | 8.77% | ROCE | 29.17% |
| ROA | 11% | ROE | -113% | Altman Z Score | 2.6 | Piotroski Score | 7 |
| Current Ratio | 0.78 | Quick Ratio | 0.69 | Cash Ratio | 0.05 | Op. CF Ratio | 0.12 |
| Debt/Equity | -7.42 | Debt/Assets | 0.81 | Lt Debt/Equity | -6.19 | Lt Debt/Cap. | 1.2 |
| Intrst Cov. | 5.21 | Inventory Turnover | 33.63 | Asset Turnover | 1.29 | Receivables Turnover | 6.35 |
| Enterprise Value | $142.34B | P/E Ratio | 14.75 |
| Forward P/E | 13.35 | PEG Ratio | 1.24 |
| P/S Ratio | 5.76 | P/B Ratio | -68.62 |
| P/CF Ratio | 40.62 | P/FCF Ratio | 74.95 |
| EPS | $28.96 | EPS Growth 1Y | 25.5% |
| EPS Growth 3Y | 46.93% | EPS Growth 5Y | 104.87% |
| Revenue Growth 1Y | 7.31% | Gross Margin | 0.28% |
| Operating Margin | 0.15% | Profit Margin | 0.09% |
| ROE | -1.13% | ROA | 0.11% |
| ROCE | 0.29% | Current Ratio | 0.78 |
| Quick Ratio | 0.69 | Cash Ratio | 0.05 |
| Debt/Equity | -7.42 | Interest Coverage | 5.21 |
| Altman Z Score | 2.6 | Piotroski Score | 7 |
HCA Healthcare (HCA) valuation & financials
HCA Healthcare (HCA) has a market capitalization of $92.48B and trades at a price-to-earnings ratio of 14.8. It operates in the Healthcare sector (Medical - Care Facilities).
HCA Healthcare's revenue grew +7.3% over the last year.
HCA Healthcare's next earnings report is scheduled for October 23, 2026 before market open; analysts estimate EPS of $6.75. Check the earnings calendar to see all companies reporting this week.
HCA Healthcare (HCA) — frequently asked questions
When does HCA Healthcare (HCA) report earnings next?
HCA Healthcare is expected to report earnings on October 23, 2026 before market open. Analysts estimate EPS of $6.75.
What is HCA Healthcare's market cap?
HCA Healthcare (HCA) has a market capitalization of $92.48B.
What is HCA's P/E ratio?
HCA Healthcare trades at a price-to-earnings ratio of 14.8, with trailing twelve-month EPS of $28.96.
How fast is HCA Healthcare growing?
HCA Healthcare's revenue grew +7.3% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)